Numab

0 followers


Numab Therapeutics is an oncology-focused biopharmaceutical company based in the Zurich-area, Switzerland. At Numab, they are writing the next chapter in cancer immunotherapy by creating multi-specific antibodies that enable the pursuit of novel therapeutic strategies.

Industries

Employees

11-50

Links

Org chart

David Urech
Chief Executive Officer

David Urech

Collapse
Sebastian Meyer
Chief Operating Officer
Roland Helfenstein
Chief Financial Officer
James Singleton
General Counsel And Board Secretary
Daniel Snell
SVP of Research & Preclinical Development
Stefan Warmuth
SVP of Technology & CMC
Tea Gunde
VP, Discovery
Piritta Felker
Head Quality Assurance
Martin Stern
SVP Clinical Development
Ivo Grgic
Director Business Development
Maureen Cleaver
Senior Director, Clinical Program Management
Josie Adams
Associate Director Clinical Operations